ASCO Conference Coverage
Seventy percent of Americans surveyed in this year's National Cancer Opinion Survey were unaware that alcohol is a well-established and modifiable risk factor for cancer, the authors noted.
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein demonstrated promising results.
ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.
ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.
CancerLinQ® Ambassadors Program is launched to provide support and guidance to practices participating in CancerLinQ®.
Zoledronic acid and clodranate are the recommended bisphosphonates for the adjuvant treatment of postmenopausal patients with breast cancer.
ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.
Patients who speak to an oncology nurse prior to their first appointment are significantly more likely to be retained for their treatment.
A hematologic multidisciplinary oral chemotherapy clinic established at a community hospital identified adverse events early and reduced ED visits.
Among patients with myeloproliferative neoplasms, men with primary myelofibrosis diagnosed after 2006 are at the highest risk of developing secondary acute myeloid leukemia (AML).
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|